TechConnect Innovation Program

Innovative Technologies to Effectively Treat Multi-Drug Resistant and/or Biofilm-Embedded Bacteria

Innovative Surface Technologies, Inc., Minnesota, United States

TECHNOLOGY SUMMARY

The technology prototype is a medicated wound dressing formulation containing a novel drug combination effective against common multi-drug resistant wound pathogens. The technology combines several desirable characteristics including nanofibrillar barrier, hemostatic activity, antibiofilm efficacy, and controlled release.

Primary Application Area: Pharmaceuticals & Personal Care

Technology Development Status: Prototype

Technology Readiness Level: TRL 6

FIGURES OF MERIT

Value Proposition: 1) Prevention of MDR skin infections: hospitals are financially incentivized to prevent nosocomial skin infections such as SSI. Average cost per infected patient ranges from $11,874 - $34,670, higher for MDR infections.

2) Treatment of MDR skin infections: effective outpatient treatment of nosocomial and community acquired MDR skin infections.

SHOWCASE SUMMARY

Organization Type: Commercial Startup (C+)

National Innovation Awardee

Showcase Booth #: 422

Website: www.isurtec.com

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date: Phase I SBIR NIH/NIGM R43GM093398 $172,763
Innovative technologies to effectively treat multi-drug resistant and/or biofilm-embedded bacteria.
09/30/10-03/29/13

Primary Sources of Funding: Personal Savings, Federal Grant

Looking for: Both Funding and Development Partners